HALDOL
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
May 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HALDOL (haloperidol) is a small-molecule antipsychotic approved in 1971 for treating schizophrenia in adults via injectable formulation. It works primarily as a dopamine D2 receptor antagonist in the central nervous system, with secondary activity at alpha-1 adrenergic receptors. The mechanism effectively reduces psychotic symptoms through dopaminergic modulation.
LOE Approaching
As LOE approaches with moderate competitive pressure (30), brand teams face contraction; focus shifts to niche positioning and retention of long-standing patient populations rather than market expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT
Started Jun 2013
0Migraine HeadachesNauseaRestlessness
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Started Apr 1987
30 enrolled
Psychosis
Career Relevance
Working on HALDOL offers limited career growth due to its LOE-approaching lifecycle and absence of active job openings (0 linked positions). This role is best suited for professionals seeking stability in a legacy brand or transition experience rather than high-impact commercial expansion.
Brand Manager
Worked on HALDOL at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.